NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation
Authors
Keywords
-
Journal
LEUKEMIA
Volume 30, Issue 1, Pages 182-189
Publisher
Springer Nature
Online
2015-07-13
DOI
10.1038/leu.2015.182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
- (2014) Michele Dal Bo et al. ANNALS OF HEMATOLOGY
- Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
- (2014) S. Stilgenbauer et al. BLOOD
- Therapeutic modulation of Notch signalling — are we there yet?
- (2014) Emma R. Andersson et al. NATURE REVIEWS DRUG DISCOVERY
- Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment
- (2013) Michael Hallek AMERICAN JOURNAL OF HEMATOLOGY
- Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia
- (2013) D. Rossi et al. BLOOD
- Dynamic binding of RBPJ is determined by Notch signaling status
- (2013) D. Castel et al. GENES & DEVELOPMENT
- A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia
- (2013) P Sportoletti et al. LEUKEMIA
- Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
- (2013) F Arruga et al. LEUKEMIA
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- Clinical significance of c.7544-7545 delCTNOTCH1mutation in chronic lymphocytic leukaemia
- (2012) Giovanni Del Poeta et al. BRITISH JOURNAL OF HAEMATOLOGY
- The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes
- (2012) R Bomben et al. LEUKEMIA
- The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells
- (2012) A Zucchetto et al. LEUKEMIA
- NOTCH1 mutations in CLL associated with trisomy 12
- (2011) V. Balatti et al. BLOOD
- Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
- (2011) D. Rossi et al. BLOOD
- NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL
- (2011) I. Del Giudice et al. HAEMATOLOGICA
- Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think: Table I.
- (2011) Camille Lobry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia
- (2011) I Saborit-Villarroya et al. LEUKEMIA
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
- (2011) Víctor Quesada et al. NATURE GENETICS
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functions of Notch Signaling in the Immune System: Consensus and Controversies
- (2010) Julie S. Yuan et al. Annual Review of Immunology
- Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia
- (2010) Maddalena Paganin et al. BLOOD REVIEWS
- NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL
- (2010) Paolo Sportoletti et al. BRITISH JOURNAL OF HAEMATOLOGY
- HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells
- (2010) R Shimizu et al. LEUKEMIA
- Escape mechanisms from antibody therapy to lymphoma cells: Downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation
- (2009) Takumi Sugimoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
- (2009) J. Hiraga et al. BLOOD
- Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
- (2008) E. Rosati et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients
- (2008) Constantine S. Tam et al. BRITISH JOURNAL OF HAEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More